Experience

Vaxcyte Announces $862.5 Million Public Offering

February 5, 2024

Cooley advised Vaxcyte, a clinical-stage vaccine innovation company, on its $862.5 million follow-on public offering.

Read more

Related contacts

John McKenna
Partner, Palo Alto
Mark Weeks
Partner, Palo Alto
David D. Kim
Associate, San Francisco
Megan Ji
Associate, Seattle
Victoria Comesañas
Associate, Palo Alto
Megan Stallworth
Associate, Palo Alto
Charlie Kim
Partner, San Diego
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, New York
Mika Reiner Mayer
Partner, Palo Alto
Kimberly Bolin
Patent Agent, Palo Alto
Eileen Marshall
Partner, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Procyrion Closes $57.7 Million Series E Financing

February 5, 2024

Cooley advised Procyrion, a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, on the close of its $57.7 million Series E financing, including the conversion of $10 million in interim financing.

Read more

Related contacts

Mark Weeks
Partner, Palo Alto
Kate Nichols
Partner, Palo Alto
Kealan Santistevan
Associate, Palo Alto
Jonathan Gonzalez
Associate, Palo Alto
Jenny Du
Associate, Palo Alto
Debbie Wilkins
Paralegal Specialist, Palo Alto

Related Practices & Industries

Apollo Endosurgery to Be Acquired by Boston Scientific

February 1, 2023

Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.

Read more

Related contacts

Mark Weeks
Partner, Palo Alto
Ben Beerle
Partner, San Francisco
Milson Yu
Partner, Palo Alto
John McKenna
Partner, Palo Alto
Matthew D. Silverman
Special Counsel, San Diego
Sangitha Palaniappa
Associate, Palo Alto
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Sarah Lightdale
Partner, New York
Pat Mitchell
Partner, Boston
Howard Morse
Partner, Washington, DC
Jason Savich
Partner, San Francisco
Charity Williams
Partner, San Diego
Jeff Goldman
Special Counsel, Palo Alto
Christine Graham
Special Counsel, London
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Stella Sarma
Special Counsel, Brussels
Karen Tsai
Special Counsel, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Bae
Associate, Washington, DC
Victoria Comesañas
Associate, Palo Alto
Jessica Dallas
Associate, Palo Alto
Katherine Denby
Associate, Washington, DC
Zack Gong
Associate, Shanghai
Wyatt Kernell
Associate, New York
Kristina Krasnikova
Associate, Palo Alto
Daniel Lac
Associate, San Diego
Edmond Lay
Associate, San Diego
James Lin
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Greg Reith
Associate, Washington, DC
Erica Russell
Associate, San Francisco
Jennifer Shanley
Special Counsel, New York
Rubin Waranch
Associate, Washington, DC
Katie Weeks
Associate, Palo Alto
Freddy Yip
Associate, Hong Kong
Jovian Marcelo
Associate, Palo Alto

Tmunity Therapeutics Agrees to Sell to Kite

December 28, 2022

Cooley advised Tmunity Therapeutics, a clinical-stage biotechnology company, on its agreement to sell to Kite, a global biopharmaceutical company. Partners Mark Weeks, Ben Beerle and Marya Postner led the Cooley team.

Read more

Related contacts

Mark Weeks
Partner, Palo Alto
Ben Beerle
Partner, San Francisco
Marya Postner
Partner, Palo Alto
Chen Chen
Associate, Palo Alto
Jenny Ge
Associate, Los Angeles Santa Monica
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Todd Gluth
Partner, San Diego
Kate Hillier
Partner, Seattle
Phil Mitchell
Partner, New York
Howard Morse
Partner, Washington, DC
David Walsh
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington, DC
Stella Sarma
Special Counsel, Brussels
Andrew Bae
Associate, Washington, DC
Baasit Bhutta
Associate, Colorado
Paula Fleckenstein
Associate, Reston
John Forrest
Associate, Boston
Joyce Li
Associate, Chicago
Lindsey O'Crump
Associate, Washington, DC
Patrick Sharma
Associate, Los Angeles Santa Monica
Rubin Waranch
Associate, Washington, DC
Freddy Yip
Associate, Hong Kong

Related Practices & Industries

Rani Therapeutics – $73 Million IPO

July 31, 2021

Cooley advised Rani Therapeutics on its $73.3 million initial public offering of 6,666,667 shares of Class A common stock. Rani Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol RANI, is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics. Partners Josh Seidenfeld, Mark Weeks, John McKenna and Charlie Kim led the Cooley team.

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Mark Weeks
Partner, Palo Alto
John McKenna
Partner, Palo Alto
Charlie Kim
Partner, San Diego
Marina Remennik
Special Counsel, Palo Alto
Megan Ji
Associate, Seattle
Rachel Lydon
Associate, San Diego
Karen Gustavson
Associate, Seattle

Related Practices & Industries

View more

Rankings & accolades

Chambers USA: Life Sciences: Corporate/Commercial – California (2020 – 2023)

Adept at representing and advising emerging life sciences companies throughout their growth, from pre-incorporation to M&A.

Chambers USA: Life Sciences: Corporate/Commercial – California (2022)